This is my archive
Lisa A. Schwartz
Associate Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania Lisa A. Schwartz, PhD, is an Innovation Faculty member at the Penn Center for Cancer Care Innovation…
David Dougherty
David W. Dougherty, MD, MBA, is an Innovation Faculty member at the Penn Center for Cancer Care Innovation (PC3I) and the Deputy Director of Clinical Services at the Abramson Cancer…
A Novel CRC Screening Decision Aid for Older Adults with Low Health Literacy
Project Description In the United States, 33% of colorectal cancer (CRC) diagnoses and 46% of CRC deaths occur in adults over the age of 75. While there are benefits…
Demonstrating the Value, Safety, and Feasibility of Telehealth in Clinical Trials
Project Description The use of telehealth increased rapidly and dramatically as a form of healthcare delivery at the onset of the COVID-19 pandemic. This has created opportunities to reexamine…
First Intervention on Financial Toxicity in Gynecologic Oncology
Project Description Gynecologic cancers are the third most common cancer in the United States. While advances such as multi-modal therapeutics have had a positive impact on care and overall…
Catherine Lai
Catherine Lai, MD, MPH, is an Innovation Faculty member at the Penn Center for Cancer Care Innovation (PC3I) and the Physician Leader of the Leukemia Clinical Research Unit at Abramson…
ISC3: Penn Implementation Science Center in Cancer Control
Project Description The Penn Implementation Science Center in Cancer Control (ISC3) is a $4.9 million, five-year grant from the National Cancer Institute that is part of the national network…
Empowering Pediatric Patients through Patient-Reported Symptom Monitoring
Project Description While clinician reports are often the standard for recording adverse side effects of cancer treatment, patient reported outcomes (PROs) are an increasingly important assessment tool through which…
Optimizing Biomarker Detection and Extending Life for Patients with Non-Small Cell Lung Cancer
Project Description When patients are diagnosed with metastatic, non-squamous non-small cell lung cancer (NSCLC), biomarker testing is crucial to determine the optimal treatment. For example, for the 30% of…
PROSPR: Population-based Research to Optimize the Screening Process
Project Description Lung cancer is the leading cause of cancer deaths, with the lowest 5-year relative survival rates of all cancer types. Lung cancer incidence and mortality rates are…